# Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue

> **NCT06905587** · PHASE3 · RECRUITING · sponsor: **Odense University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Brain Tumor, Pediatric
- Cancer-related Fatigue
- Methylphenidate

## Interventions

- **DRUG:** Methylphenidate (MPH)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06905587
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-02
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06905587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06905587, "Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06905587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*